Understanding the role of Cripto-1 in cancer progression and therapeutic strategies

Qingfang Zeng1, Yuzhen Gao2, Ying Zhou3

  • 1Department of Gastroenterology, The 910 Hospital of Joint Logistic, Support Force Hua-Yuan Road No.180, Quanzhou City, Fujian Province, 362000, China.

Insights

Cripto-1 protein drives human growth but promotes cancer metastasis by initiating epithelial to mesenchymal transition (EMT). This review explores Cripto-1

Area of Science:

  • Developmental Biology
  • Cancer Biology
  • Molecular Oncology

Background:

  • Cripto-1 is a crucial protein in embryonic development, regulating epithelial to mesenchymal transition (EMT).
  • Elevated Cripto-1 levels are observed in most malignancies, correlating with tumor progression.
  • Cripto-1 facilitates cell migration and metastasis by inducing EMT.

Purpose of the Study:

  • To elucidate the role of Cripto-1 in common human cancers.
  • To review therapeutic strategies targeting Cripto-1 for cancer treatment.

Main Methods:

  • Review of existing literature on Cripto-1 function in embryogenesis and cancer.
  • Analysis of Cripto-1's mechanisms in promoting epithelial to mesenchymal transition (EMT).
  • Summary of therapeutic interventions aimed at inhibiting Cripto-1 activity.

Main Results:

  • Cripto-1's dual role: essential for embryonic growth but detrimental in cancer metastasis.
  • Cripto-1 facilitates cancer cell migration through EMT, enabling invasion and spread.
  • High Cripto-1 expression is a hallmark of many malignant tumors.

Conclusions:

  • Cripto-1 is a significant factor in cancer progression and metastasis.
  • Targeting Cripto-1 offers a promising therapeutic avenue for various cancers.
  • Further research into Cripto-1-based therapies is warranted.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K